Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Jan;79(2):579–582. doi: 10.1073/pnas.79.2.579

Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

A M Prince, H Ikram, T P Hopp
PMCID: PMC345788  PMID: 6176997

Abstract

On the basis of theoretical considerations, a peptide (H peptide) was synthesized by Hopp and Woods [Hopp, T. P. & Woods, K. R. (1981) Proc. Natl. Acad. Sci. USA 78, 3824---3828]. This peptide contains a sequence of six amino acids postulated to represent the major epitope, or antibody-combining site, of hepatitis B virus surface antigen (HBsAg). We have used passive hemagglutination inhibition with monospecific antibodies against the a, d, and y subdeterminants of this antigen and against human serum albumin to investigate the antigenic specificities on this peptide, and we have found it to contain the HBsAg/a and HBsAg/d but not HBsAg/y or human serum albumin subdeterminants. When the peptide was conjugated onto human erythrocytes and injected into mice, it induced the formation of anti-HBsAg with and without the use of Freund's adjuvant. If anti-HBsAg/a confers immunity to infection with hepatitis B virus, as is generally thought, these findings may permit the development of a synthetic vaccine lacking all unnecessary antigenic determinants.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bancroft W. H., Mundon F. K., Russell P. K. Detection of additional antigenic determinants of hepatitis B antigen. J Immunol. 1972 Oct;109(4):842–848. [PubMed] [Google Scholar]
  2. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  3. Burrell C. J., Mackay P., Greenaway P. J., Hofschneider P. H., Murray K. Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature. 1979 May 3;279(5708):43–47. doi: 10.1038/279043a0. [DOI] [PubMed] [Google Scholar]
  4. Charnay P., Gervais M., Louise A., Galibert F., Tiollais P. Biosynthesis of hepatitis B virus surface antigen in Escherichia coli. Nature. 1980 Aug 28;286(5776):893–895. doi: 10.1038/286893a0. [DOI] [PubMed] [Google Scholar]
  5. Charnay P., Mandart E., Hampe A., Fitoussi F., Tiollais P., Galibert F. Localization on the viral genome and nucleotide sequence of the gene coding for the two major polypeptides of the hepatitis B surface antigen (HBs Ag). Nucleic Acids Res. 1979 Sep 25;7(2):335–346. doi: 10.1093/nar/7.2.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Charnay P., Pourcel C., Louise A., Fritsch A., Tiollais P. Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A. 1979 May;76(5):2222–2226. doi: 10.1073/pnas.76.5.2222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dane D. S., Cameron C. H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970 Apr 4;1(7649):695–698. doi: 10.1016/s0140-6736(70)90926-8. [DOI] [PubMed] [Google Scholar]
  8. Dubois M. F., Pourcel C., Rousset S., Chany C., Tiollais P. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4549–4553. doi: 10.1073/pnas.77.8.4549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grady G. F., Lee V. A., Prince A. M., Gitnick G. L., Fawaz K. A., Vyas G. N., Levitt M. D., Senior J. R., Galambos J. T., Bynum T. E. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978 Nov;138(5):625–638. doi: 10.1093/infdis/138.5.625. [DOI] [PubMed] [Google Scholar]
  10. Hilleman M. R., Buynak E. B., Roehm R. R., Tytell A. A., Bertland A. U., Lampson G. P. Purified and inactivated human hepatitis B vaccine: progress report. Am J Med Sci. 1975 Sep-Oct;270(2):401–404. doi: 10.1097/00000441-197509000-00025. [DOI] [PubMed] [Google Scholar]
  11. Hopp T. P. A synthetic peptide with hepatitis B surface antigen reactivity. Mol Immunol. 1981 Sep;18(9):869–872. doi: 10.1016/0161-5890(81)90009-2. [DOI] [PubMed] [Google Scholar]
  12. Hopp T. P., Woods K. R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824–3828. doi: 10.1073/pnas.78.6.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ikram H., Prince A. M. A method for coupling the hepatitis B surface antigen to aldehyde-fixed erythrocytes for use in passive hemagglutination. J Virol Methods. 1981 Apr;2(5):269–275. doi: 10.1016/0166-0934(81)90025-2. [DOI] [PubMed] [Google Scholar]
  14. Krugman S., Giles J. P., Hammond J. Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA. 1971 Dec 13;218(11):1665–1670. [PubMed] [Google Scholar]
  15. Krugman S., Giles J. P., Hammond J. Viral hepatitis, type B (MS-2 strain). Studies on active immunization. JAMA. 1971 Jul 5;217(1):41–45. [PubMed] [Google Scholar]
  16. Langbeheim H., Arnon R., Sela M. Antiviral effect on MS-2 coliphage obtained with a synthetic antigen. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4636–4640. doi: 10.1073/pnas.73.12.4636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lerner R. A., Green N., Alexander H., Liu F. T., Sutcliffe J. G., Shinnick T. M. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3403–3407. doi: 10.1073/pnas.78.6.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maupas P., Goudeau A., Coursaget P., Drucker J., Bagros P. Immunisation against hepatitis B in man. Lancet. 1976 Jun 26;1(7974):1367–1370. doi: 10.1016/s0140-6736(76)93023-3. [DOI] [PubMed] [Google Scholar]
  19. McAuliffe V. J., Purcell R. H., Gerin J. L. Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis. 1980 May-Jun;2(3):470–492. doi: 10.1093/clinids/2.3.470. [DOI] [PubMed] [Google Scholar]
  20. Millman I., Hutanen H., Merino F., Bayer M. E., Blumberg B. S. Australia antigen: physical and chemical properties. Res Commun Chem Pathol Pharmacol. 1971 Jul-Sep;2(4):667–686. [PubMed] [Google Scholar]
  21. Moriarty A. M., Hoyer B. H., Shih J. W., Gerin J. L., Hamer D. H. Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2606–2610. doi: 10.1073/pnas.78.4.2606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Murphy B. L., Maynard J. E., Le Bouvier G. L. Viral subtypes and cross-protection in hepatitis B virus infections of chimpanzees. Intervirology. 1974;3(5-6):378–381. doi: 10.1159/000149775. [DOI] [PubMed] [Google Scholar]
  23. Neurath A. R., Strick N. Radioimmunoassay for albumin-binding sites associated with HBsAg: correlation of results with the presence of e-antigen in serum. Intervirology. 1979;11(2):128–132. doi: 10.1159/000149024. [DOI] [PubMed] [Google Scholar]
  24. Neurath A. R., Trepo C., Chen M., Prince A. M. Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol. 1976 Mar;30(3):277–285. doi: 10.1099/0022-1317-30-3-277. [DOI] [PubMed] [Google Scholar]
  25. PRINCE A. M., FUJI H., GERSHON R. K. IMMUNOHISTOCHEMICAL STUDIES ON THE ETIOLOGY OF ANICTERIC HEPATITIS IN KOREA. Am J Hyg. 1964 May;79:365–381. doi: 10.1093/oxfordjournals.aje.a120391. [DOI] [PubMed] [Google Scholar]
  26. Pasek M., Goto T., Gilbert W., Zink B., Schaller H., MacKay P., Leadbetter G., Murray K. Hepatitis B virus genes and their expression in E. coli. Nature. 1979 Dec 6;282(5739):575–579. doi: 10.1038/282575a0. [DOI] [PubMed] [Google Scholar]
  27. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Prince A. M., Burke K. Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science. 1970 Aug 7;169(3945):593–595. doi: 10.1126/science.169.3945.593. [DOI] [PubMed] [Google Scholar]
  29. Prince A. M. Detection of serum hepatitis virus carriers by testing for the SH (Australia) antigen. A review of current methodology. Vox Sang. 1970 Nov-Dec;19(5):417–424. doi: 10.1111/j.1423-0410.1970.tb01772.x. [DOI] [PubMed] [Google Scholar]
  30. Prince A. M., Gershon R. K. The etiology of chronic active hepatitis in Korea. Yale J Biol Med. 1979 Mar-Apr;52(2):159–167. [PMC free article] [PubMed] [Google Scholar]
  31. Prince A. M., Szmuness W., Mann M. K., Vyas G. N., Grady G. F., Shapiro F. L., Suki W. N., Freidman E. A., Avram M. M., Stenzel K. H. Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis. 1978 Feb;137(2):131–144. doi: 10.1093/infdis/137.2.131. [DOI] [PubMed] [Google Scholar]
  32. Prince A. M., Szmuness W., Woods K. R., Grady G. F. Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections. N Engl J Med. 1971 Oct 21;285(17):933–938. doi: 10.1056/NEJM197110212851702. [DOI] [PubMed] [Google Scholar]
  33. Purcell R. H., Gerin J. L. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci. 1975 Sep-Oct;270(2):395–399. [PubMed] [Google Scholar]
  34. Seeff L. B., Wright E. C., Zimmerman H. J., Alter H. J., Dietz A. A., Felsher B. F., Finkelstein J. D., Garcia-Pont P., Gerin J. L., Greenlee H. B. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med. 1978 Mar;88(3):285–293. doi: 10.7326/0003-4819-88-3-285. [DOI] [PubMed] [Google Scholar]
  35. Sninsky J. J., Siddiqui A., Robinson W. S., Cohen S. N. Cloning and endonuclease mapping of the hepatitis B viral genome. Nature. 1979 May 24;279(5711):346–348. doi: 10.1038/279346a0. [DOI] [PubMed] [Google Scholar]
  36. Summers J., O'Connell A., Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4597–4601. doi: 10.1073/pnas.72.11.4597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  38. Trepo C., Prince A. M., Meliconi R., Eddlestone A. L., Williams R., Tage-Jensen U., Nielsen J. O. Safety of hepatitis-B vaccines containing intact 20 nm particles. Lancet. 1979 Mar 3;1(8114):488–488. doi: 10.1016/s0140-6736(79)90836-5. [DOI] [PubMed] [Google Scholar]
  39. Valenzuela P., Gray P., Quiroga M., Zaldivar J., Goodman H. M., Rutter W. J. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature. 1979 Aug 30;280(5725):815–819. doi: 10.1038/280815a0. [DOI] [PubMed] [Google Scholar]
  40. Vnek J., Prince A. M., Hashimoto N., Ikram H. Association of normal serum protein antigens with chimpanzee hepatitis B surface antigen particles. J Med Virol. 1978;2(4):319–333. doi: 10.1002/jmv.1890020405. [DOI] [PubMed] [Google Scholar]
  41. Vyas G. N., Rao K. R., Ibrahim A. B. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science. 1972 Dec 22;178(4067):1300–1301. doi: 10.1126/science.178.4067.1300. [DOI] [PubMed] [Google Scholar]
  42. Young J. D., Benjamini E., Stewart J. M., Leung C. Y. Immunochemical studies on tobacco mosaic virus protein. V. The solid-phase synthesis of peptides of an antigenically active decapeptide of tobacco mosaic virus protein and the reaction of these peptides with antibodies to the whole protein. Biochemistry. 1967 May;6(5):1455–1460. doi: 10.1021/bi00857a030. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES